Catalio Conversations

What if the reason ~95% of cancer drugs fail in the clinic isn't the drug at all – but the patient they were given to? In this episode of Catalio Conversations, Martha Petrocheilos sits with Ron Alfa, Co-Founder & CEO of Noetik, who reveals a radically contrarian thesis: the industry is great at making drugs, but has never cracked how to match the right drug to the right patient, and that fixi...

Explore the future of healthcare with AI that could help hospitals catch life-threatening conditions before they turn critical! In this episode of Catalio Conversations, Martha Petrocheilos sits with Suchi Saria, founder and CEO of Bayesian Health, who reveals how combining cutting-edge AI with deep clinical integration is rewriting the rules of patient care – think a sepsis monitor that flags dan...

Explore the future of drug development with AI that could compress decades of research into just years! Joining us at Catalio Conversations is Tom Miller, co-founder of Iambic, where he reveals how combining cutting-edge neural models with high-throughput experimentation is rewriting the rules of pharmaceutical innovation – think a cancer drug designed, optimized, and FDA-approved in under two yea...

Unlock the future of drug discovery with AI-powered robots that could revolutionize science as we know it! Joining us at Catalio Conversations is Michelle Lee, CEO of Medra AI, where she reveals how combining AI & robotics is creating the world's most advanced autonomous labs – think 100 robots working overnight to accelerate cures for disease! Michelle’s journey from chemical engineering and...